Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Nov;24(5):637–643. doi: 10.1111/j.1365-2125.1987.tb03223.x

Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.

A L Leeman 1, C J O'Neill 1, P W Nicholson 1, A A Deshmukh 1, M J Denham 1, J P Royston 1, R J Dobbs 1, S M Dobbs 1
PMCID: PMC1386336  PMID: 3325092

Abstract

1. Insomnia is an even more frequent complaint in elderly patients with Parkinson's disease than might be expected from the effect of age alone on sleep. 2. A double-blind, placebo-controlled trial in eleven patients with Parkinson's disease of mean (s.d.) age 80(5) years, showed that nocturnal dosing with levodopa produced a clinically significant improvement in sleep both as assessed subjectively and by measurement of number of spontaneous moves in bed. 3. Despite the long interval between tablet administration and morning assessment, walking time was faster on mornings following active treatment.

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenasy J. J., Yahr M. D. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology. 1985 Apr;35(4):527–532. doi: 10.1212/wnl.35.4.527. [DOI] [PubMed] [Google Scholar]
  2. Bergonzi P., Chiurulla C., Cianchetti C., Tempesta E. Clinical pharmacology as an approach to the study of biochemical sleep mechanisms: the action of L-dopa. Confin Neurol. 1974;36(1):5–22. doi: 10.1159/000102780. [DOI] [PubMed] [Google Scholar]
  3. COX G. H., MARLEY E. The estimation of motility during rest or sleep. J Neurol Neurosurg Psychiatry. 1959 Feb;22(1):57–60. doi: 10.1136/jnnp.22.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crowley T. J., Hydinger-Macdonald M. Bedtime flurazepam and the human circadian rhythm of spontaneous motility. Psychopharmacology (Berl) 1979 Apr 11;62(2):157–161. doi: 10.1007/BF00427130. [DOI] [PubMed] [Google Scholar]
  5. HINTON J. M., MARLEY E. The effects of meprobamate and pentobarbitone sodium on sleep and motility during sleep: a controlled trial with psychiatric patients. J Neurol Neurosurg Psychiatry. 1959 May;22(2):137–140. doi: 10.1136/jnnp.22.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HINTON J. M. The actions of amylobarbitone sodium, butobarbitone and quinalbarbitone sodium upon insomnia and nocturnal restlessness compared in psychiatric patients. Br J Pharmacol Chemother. 1961 Feb;16:82–89. doi: 10.1111/j.1476-5381.1961.tb00300.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Herbert M. Studies of sleep in the elderly. Age Ageing. 1978;Suppl:41–49. doi: 10.1093/ageing/7.suppl.41. [DOI] [PubMed] [Google Scholar]
  8. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  9. Horvath T. B., Meares R. A. L-dopa and arousal. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):416–420. doi: 10.1136/jnnp.37.4.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jenkins R. B., Groh R. H. Mental symptoms in Parkinsonian patients treated with L-dopa. Lancet. 1970 Jul 25;2(7665):177–179. doi: 10.1016/s0140-6736(70)92535-3. [DOI] [PubMed] [Google Scholar]
  11. Kales A., Ansel R. D., Markham C. H., Scharf M. B., Tan T. L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther. 1971 Mar-Apr;12(2):397–406. doi: 10.1002/cpt1971122part2397. [DOI] [PubMed] [Google Scholar]
  12. Kales A., Wilson T., Kales J. D., Jacobson A., Paulson M. J., Kollar E., Walter R. D. Measurements of all-night sleep in normal elderly persons: effects of aging. J Am Geriatr Soc. 1967 May;15(5):405–414. doi: 10.1111/j.1532-5415.1967.tb02072.x. [DOI] [PubMed] [Google Scholar]
  13. Karson C. N., Burns R. S., LeWitt P. A., Foster N. L., Newman R. P. Blink rates and disorders of movement. Neurology. 1984 May;34(5):677–678. doi: 10.1212/wnl.34.5.677. [DOI] [PubMed] [Google Scholar]
  14. Lees A. J., Shaw K. M., Kohout L. J., Stern G. M., Elsworth J. D., Sandler M., Youdim M. B. Deprenyl in Parkinson's disease. Lancet. 1977 Oct 15;2(8042):791–795. doi: 10.1016/s0140-6736(77)90725-5. [DOI] [PubMed] [Google Scholar]
  15. Lesser R. P., Fahn S., Snider S. R., Cote L. J., Isgreen W. P., Barrett R. E. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 1979 Sep;29(9 Pt 1):1253–1260. doi: 10.1212/wnl.29.9_part_1.1253. [DOI] [PubMed] [Google Scholar]
  16. Marsden C. D., Parkes J. D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1976 Feb 7;1(7954):292–296. doi: 10.1016/s0140-6736(76)91416-1. [DOI] [PubMed] [Google Scholar]
  17. Nausieda P. A., Weiner W. J., Kaplan L. R., Weber S., Klawans H. L. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol. 1982;5(2):183–194. doi: 10.1097/00002826-198205020-00003. [DOI] [PubMed] [Google Scholar]
  18. Parkes J. D. Variability in Parkinson's disease; clinical aspects, causes and treatment. Acta Neurol Scand Suppl. 1983;95:27–35. doi: 10.1111/j.1600-0404.1983.tb01514.x. [DOI] [PubMed] [Google Scholar]
  19. Quinn N. P., Husain F. A. Parkinson's disease. Br Med J (Clin Res Ed) 1986 Aug 9;293(6543):379–382. doi: 10.1136/bmj.293.6543.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Quinn N. P., Koller W. C., Lang A. E., Marsden C. D. Painful Parkinson's disease. Lancet. 1986 Jun 14;1(8494):1366–1369. doi: 10.1016/s0140-6736(86)91674-0. [DOI] [PubMed] [Google Scholar]
  21. Snider S. R., Fahn S., Isgreen W. P., Cote L. J. Primary sensory symptoms in parkinsonism. Neurology. 1976 May;26(5):423–429. doi: 10.1212/wnl.26.5.423. [DOI] [PubMed] [Google Scholar]
  22. Stephen P. J., Williamson J. Drug-induced parkinsonism in the elderly. Lancet. 1984 Nov 10;2(8411):1082–1083. doi: 10.1016/s0140-6736(84)91516-2. [DOI] [PubMed] [Google Scholar]
  23. Sweet R. D., McDowell F. H. Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients. Ann Intern Med. 1975 Oct;83(4):456–463. doi: 10.7326/0003-4819-83-4-456. [DOI] [PubMed] [Google Scholar]
  24. Zametkin A. J., Stevens J. R., Pittman R. Ontogeny of spontaneous blinking and of habituation of the blink reflex. Ann Neurol. 1979 May;5(5):453–457. doi: 10.1002/ana.410050509. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES